Day 3 #TVT2023, kicking off with more #LAAO in the Abridged Operator’s Manual! Amazing panel! 🌵 ☀️ 🫀 Cardiovascular Research Foundation Jacqueline Saw Dr. Devi G Nair Horst Sievert @redaibrahim Vivian Ng Jonathan Schwartz, MD @apostolostzik Dr.Tzikas Dr.Sommer

This week a world-renowned TAVI program tweeted out its congrats to an ANP lead operator. Cardiology orgs were caught flat-footed. tctmd.com/news/nurse-pra…

Congratulations, Dr. RTHahnMD, the recipient of the American Society of Echocardiography's 2023 Physician Lifetime Achievement Award! We salute your outstanding achievements and leadership in #cardiology and #echocardiography. Your dedication to service, research, and teaching is truly inspiring!

Happening now- #SCCT2023 📢life time journey of TAVR 📢Valve in valve 📢HALT 📢Structural valve deterioration Omar Khalique Vivian Ng Jonathon Leipsic Jonathan Weir-McCall Anna Reid

Vivian Ng highlighting the nuanced decision making and the consideration that go into patient selection for TAVR Heart_SCCT #SCCT2023 #YesCCT

Today is the 10th Anniversary of the FIH Transseptal ViMAC. Thankful for what we have learned together, and more importantly… for your friendship and collaboration. Thank you all! With deepest gratitude🙏 Mayo Clinic CV

Join us Sept 8 for a Knowledge Lab to gain insights into the latest advances in thrombus detection & treatment! Learn how to provide the best care for your patients & advance your professional practice. Omar Khalique Roosha Parikh Vivian Ng ow.ly/mogE50PGwcJ

Celebrating a milestone in cardiology history! On this day in 1977, Dr. Andreas Grüntzig pioneered coronary angioplasty, revolutionizing patient care. TCTMD proudly honors International Day for Interventional Cardiology. Let's celebrate the life-saving innovations and dedicated

#LAAO device implant depth is an independent risk factor for DRT, and deeper device implant and larger uncovered LAA areas have a higher incidence of DRT. bit.ly/3Ru8eBL #JACCINT #CardioTwitter Pedro Cepas Luis Nombela-Franco Laura Sanchis Julio Farjat Pasos

MViV, MViR & ViMAC with Sapien 3 associated with sustained improvement of HF symptoms & QoL @ 5 years. Stable THV function in all groups. MViV had excellent survival @ 5 years, lower survival in MViR & ViMAC. Thank you all collaborators! Mayo Clinic CV authors.elsevier.com/a/1hphO6uPJvqh…

In this issue, introduced by Vivian G. Ng, MD (Vivian Ng), we take a look at the current TAVR landscape and explore areas of continued advancement and controversy within this field. citoday.com/issues/2024-ma…

Attention interventional cardiologists. We (and our cath lab staff) have risked our lives and livelihood for long enough with heavy lead aprons. Enough is enough. SCAI Wellbeing Task Force is on your side. #SCAI2024 #CardioTwitter

American College of Cardiology Anu Lala-Trindade This year's cohort of #EmergingFaculty were incredibly talented, engaged, and humble. I'm so grateful to each of them for dedicated time to improving their educator skills. Special thanks to @KBerlacher Jane Linderbaum Salim Virani for helping to lead this course!

Had a wonderful time American College of Cardiology Heart House for the ACC Emerging Faculty Course with exceptional educators @KBerlacher Geoff Barnes Jane Linderbaum Salim Virani and amazing colleagues (could only tag 10) Thank you ACC for the hospitality and investing in the next generation!

💡Get ready for an exciting start to #NYValves2024 tomorrow! 🎉 Join us for a full day of interactive learning and training designed for all members of the #HeartTeam! Don't miss out on the opportunity to revolutionize structural heart care through a multidisciplinary approach.

#NYValves2024 Cardiovascular Research Foundation ‼️RTHahnMD presents new results balancing #SMART trial‼️ 🔹Clinical outcomes & valve durability were comparable at 5Y between small & large aortic annulus TF-TAVR patients receiving a SAPIEN 3 BEV 🔹Small annulus patients, neither post-TAVR MG nor

Some key points from Vivian Ng: Please make sure I got everything right Dr. A short 🧵 1/4 1. Device related thrombus are related to increased risk of MACE and can be partially prevented with appropriate deployment. #nyvalves2024 #medtwitter #cardiotwitter

American College of Cardiology #ACCCTR 2024-24 Clinical Trials Research cohort and faculty at Heart House! Pamela S Douglas Melvin R. Echols, MD, MSCR, FACC, FHFSA, FASPC Tracy Wang Wayne Batchelor, MD LaPrincess C. Brewer, MD, MPH Shashank Sinha, MD, MSc, FACC, FAHA, FHFSA #thefaceofcardiology

“Women are 50% more likely than men to leave IntCard…a disparity unmatched... factors (include) gender stereotypes in IntCard, including the lack-of-fit phenomena or perception of women in a male dominated field, discrimination, and harrasment.” pubmed.ncbi.nlm.nih.gov/38985493/

#TCT2024 in case you missed it! EARLY TAVR meets primary endpoint driven by Unplanned CV Hospitalization. Also prevents ⬇️ QoL! bit.ly/EARLY_TAVR NEJM TCTMD